In conclusion, we report that HRGs are expressed in variable levels in bladder cancer and mRNA expressions of HER3, HRG2β and HRG4 are decreased in muscle-invasive tumours as compared to superficial tumours. The gene discussed is ERBB3; the disease is urinary bladder carcinoma.